Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 11—November 2015
Synopsis

Ebola Virus Outbreak Investigation, Sierra Leone, September 28–November 11, 2014

Hui-Jun Lu12, Jun Qian12, David Kargbo1, Xiao-Guang Zhang2, Fan Yang2, Yi Hu2, Yang Sun2, Yu-Xi Cao2, Yong-Qiang Deng2, Hao-Xiang Su2, Foday Dafae, Yu Sun2, Cheng-Yu Wang2, Wei-Min Nie2, Chang-Qing Bai2, Zhi-Ping Xia, Kun Liu, Brima Kargbo, George F. Gao2, and Jia-Fu Jiang2Comments to Author 
Author affiliations: Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun, China (H.-J. Lu, J. Qian, Yang Sun, C.-Y. Wang, Z.-P. Xia); Ministry of Health and Sanitation, Freetown, Sierra Leone (D. Kargbo, F. Dafae, B. Kargbo); Chinese Center for Disease Control and Prevention, Beijing, China (X.-G. Zhang, Y.-X. Cao, G.-F. Gao); Chinese Academy of Medical Sciences, Beijing (F. Yang, H.-X. Su); China and Peking Union Medical College, Beijing (F. Yang, H.-X. Su); State Key Laboratory of Pathogen and Biosecurity, Beijing (Y. Hu, Y.-Q. Deng, Yu Sun, K. Liu, J.-F. Jiang); The No. 302 Hospital, Beijing (W.-M. Nie); The No. 307 Hospital, Beijing (C.-Q. Bai)

Main Article

Table 1

Demographic and clinical characteristics for suspected Ebola virus disease patients, Sierra Leone, September 28–November 11, 2014*

Characteristics No. (%) patients with positive RT-PCR results
No. (%) patients with negative RT-PCR results, n = 451
All patients, n = 563 Patients who died, n = 328 Patients who recovered, n = 235
Demographic characteristic
Sex
Female 266 (47.2) 156 (47.6) 110 (46.8) 219 (48.6)
Male 297(52.8) 172(52.4) 125(53.2) 232(51.4)
Age, y, group†
0–5 30 (5.3) 18 (5.6) 12 (5.1) 53 (12.0)
6–14 105 (18.7) 68 (21.0) 37 (15.8) 59 (13.4)
15–44 341 (61.1) 179 (55.2) 162 (69.2) 261 (59.3)
>45 82 (14.7) 59 (18.2) 23 (9.8) 67 (15.2)
Location of residence
Western Area
Rural areas 198 (35.2) 107 (32.6) 91 (38.7) 137 (30.4)
Urban areas 140 (24.9) 71 (21.6) 69 (29.4) 177 (39.2)
Northern Province
Port Loko District 191 (33.9) 131 (39.9) 60 (25.5) 71 (15.7)
Kambia District 21 (3.7) 13 (4.0) 8 (3.4) 27 (6.0)
Bombali District 10 (1.8) 5 (1.5) 5 (2.1) 23 (5.1)
Koinadugu District 2 (0.4) 1 (0.3) 1 (0.4) 5 (1.1)
Tonkolili District 0 0 0 9 (1.2)
Southern Province
Bo Town 1 (0.2) 0 1 (0.4) 0
Bonthe District
0
0
0
1 (0.1)
Signs and symptoms
Fatigue 464 (84.4) 272 (82.9) 192 (81.7) 196 (43.5)
Anorexia 467 (82.9) 278 (84.8) 189 (80.4) 208 (46.1)
Fever 426 (75.7) 260 (79.3) 166 (70.6) 210 (46.6)
Vomiting or nausea 354 (62.9) 202 (61.6) 152 (64.7) 112 (24.8)
Headache 354 (62.9) 209 (63.7) 145 (61.7) 195 (43.2)
Diarrhea 349 (62.0) 207 (63.1) 142 (60.4) 103 (22.8)
Joint pain 319 (56.7) 186 (56.7) 133 (56.6) 174 (38.6)
Abdominal pain 317 (56.3) 184 (56.1) 133 (56.6) 130 (28.8)
Muscle pain 305 (54.2) 183 (55.8) 122 (51.9) 137 (30.4)
Chest pain 226 (40.1) 123 (37.5) 103 (43.8) 96 (21.3)
Cough 212 (37.7) 113 (34.5) 99 (42.1) 101 (22.4)
Difficulty breathing 191 (33.9) 110 (33.5) 81 (35.4) 88 (19.5)
Difficulty swallowing 164 (29.1) 95 (29.0) 69 (29.4) 56 (12.4)
Conjunctivitis 161 (28.6) 95 (29.0) 66 (28.1) 34 (7.5)
Confused 151 (26.8) 88 (26.8) 63 (26.8) 50 (11.1)
Sore throat 117 (20.8) 66 (20.1) 51 (21.7) 39 (8.6)
Jaundice 102 (18.1) 63 (19.2) 39 (16.6) 42 (9.3)
Hiccups 95 (16.9) 56 (17.1) 39 (16.6) 20 (4.4)
Pain behind eyes 55 (9.8) 34 (10.4) 21 (8.9) 13 (2.9)
Skin Rash 45 (8.0) 25 (7.6) 20 (8.5) 23 (5.1)
Coma 27 (4.8) 15 (4.6) 12 (5.1) 10 (2.2)
Hemorrhage
6 (1.1)
6 (1.8)
0
7 (1.6)
Virus load, mean± SD‡ 363,078 ±28 436,515 ±26 288,403 ±30 NA

*NA, not applicable; RT-PCR, reverse transcription PCR.
†Age was not known for 5 patients with confirmed disease and 11 patients with negative test results.
‡Virus loads represent RNA copies.

Main Article

1These authors contributed equally to this article.

2These authors were members of the China Mobile Laboratory Testing Team in Sierra Leone.

Page created: October 16, 2015
Page updated: October 16, 2015
Page reviewed: October 16, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external